DuChemBIO Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Revenue	38,572	35,601	34,695
Other Revenue	-0	-	-0
Revenue	38,572	35,601	34,695
Revenue Growth (YoY)	8.35%	2.61%	-
Cost of Revenue	24,342	23,367	22,898
Gross Profit	14,230	12,234	11,797
Selling, General & Admin	5,430	5,548	5,087
Research & Development	22.57	-	205.31
Amortization of Goodwill & Intangibles	982.07	977.8	979.73
Operating Expenses	6,787	7,158	6,541
Operating Income	7,443	5,076	5,256
Interest Expense	-1,062	-1,091	-1,364
Interest & Investment Income	221.64	89.64	90.89
Earnings From Equity Investments	-24.69	1,106	-69.64
Currency Exchange Gain (Loss)	-4.77	-34.84	-7.99
Other Non Operating Income (Expenses)	-54.72	30.23	68.38
EBT Excluding Unusual Items	6,519	5,177	3,974
Gain (Loss) on Sale of Investments	207.24	387.82	92.13
Gain (Loss) on Sale of Assets	2.85	-0.18	16.28
Asset Writedown	-72.81	-	-30.7
Pretax Income	6,656	5,564	4,052
Income Tax Expense	176.72	-2,429	51.23
Net Income	6,480	7,994	4,001
Net Income to Common	6,480	7,994	4,001
Net Income Growth	-18.94%	99.82%	-
Shares Outstanding (Basic)	28	27	27
Shares Outstanding (Diluted)	28	27	27
Shares Change (YoY)	5.75%	0.43%	-
EPS (Basic)	228.61	297.54	149.54
EPS (Diluted)	228.00	297.54	149.54
EPS Growth	-23.37%	98.97%	-
Free Cash Flow	9,074	5,440	7,293
Free Cash Flow Per Share	319.36	202.48	272.63
Gross Margin	36.89%	34.36%	34.00%
Operating Margin	19.30%	14.26%	15.15%
Profit Margin	16.80%	22.45%	11.53%
Free Cash Flow Margin	23.52%	15.28%	21.02%
EBITDA	14,313	10,641	11,016
EBITDA Margin	37.11%	29.89%	31.75%
D&A For EBITDA	6,870	5,565	5,760
EBIT	7,443	5,076	5,256
EBIT Margin	19.30%	14.26%	15.15%
Effective Tax Rate	2.66%	-	1.26%
Advertising Expenses	172.04	76.18	62.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.